Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline / 부인종양
Journal of Gynecologic Oncology
;
: e30-2016.
Article
Dans Anglais
| WPRIM
| ID: wpr-213436
ABSTRACT
After human papillomavirus (HPV) vaccine guidelines published by Korean Society of Gynecologic Oncology (KSGO) in 2011, new studies have been published, leading to additional data regarding efficacy, safety, number of vaccination rounds, and ideal age of vaccine administration. We searched and reviewed the literatures focused on the efficacy of 2-dose schedule vaccination, the efficacy of 3-dose schedule vaccination in middle-aged women, the ideal age of 3-dose schedule vaccination, the safety of HPV preventive vaccine, and the ability of cross-protection of each HPV preventive vaccine. The KSGO has revised the previous guideline based on the results of the above studies.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Tumeurs du col de l'utérus
/
Facteurs âges
/
Résultat thérapeutique
/
Guides de bonnes pratiques cliniques comme sujet
/
Vaccins contre les papillomavirus
/
République de Corée
/
Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18
Type d'étude:
Guide de pratique
Limites du sujet:
Adolescent
/
Adulte
/
Enfant
/
Femelle
/
Humains
Pays comme sujet:
Asie
langue:
Anglais
Texte intégral:
Journal of Gynecologic Oncology
Année:
2016
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS